Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,297,660
  • Shares Outstanding, K 22,205
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,170 K
  • 60-Month Beta 1.13
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.09
Trade KRYS with:

Options Overview

Details
  • Implied Volatility 63.99%
  • Historical Volatility 40.82%
  • IV Percentile 54%
  • IV Rank 52.18%
  • IV High 111.01% on 11/10/20
  • IV Low 12.70% on 03/17/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 43
  • Volume Avg (30-Day) 134
  • Put/Call OI Ratio 4.45
  • Today's Open Interest 4,445
  • Open Int (30-Day) 3,810

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.74
  • Number of Estimates 3
  • High Estimate -0.69
  • Low Estimate -0.80
  • Prior Year -0.37
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.81 +6.62%
on 07/27/21
72.54 -19.44%
on 07/02/21
-9.56 (-14.06%)
since 06/30/21
3-Month
54.81 +6.62%
on 07/27/21
82.79 -29.41%
on 05/03/21
-21.00 (-26.44%)
since 04/30/21
52-Week
39.39 +48.35%
on 08/06/20
87.29 -33.05%
on 03/01/21
+15.73 (+36.83%)
since 07/30/20

Most Recent Stories

More News
Relative Strength Alert For Krystal Biotech

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

KRYS : 58.44 (-2.36%)
New Strong Sell Stocks for June 8th

ASLN, CANG, ESLT, GCI, and KRYS have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2021.

GCI : 5.77 (+1.94%)
ESLT : 132.63 (-1.27%)
KRYS : 58.44 (-2.36%)
CANG : 4.37 (+3.07%)
ASLN : 2.77 (-2.12%)
Krystal Biotech to Participate in Upcoming Investor Conferences

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced participation in two upcoming virtual investor conferences.

KRYS : 58.44 (-2.36%)
New Strong Sell Stocks for May 28th

ACET, FURY, KRYS, MRSN, and NBEV have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2021

ACET : 7.40 (-1.20%)
NBEV : 1.9100 (-1.55%)
KRYS : 58.44 (-2.36%)
MRSN : 11.00 (-1.26%)
FURY : 0.9918 (-3.71%)
New Strong Sell Stocks for May 21st

ATHM, INVO, FOUR, KRYS, and RMAX have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2021

RMAX : 34.30 (-1.10%)
ATHM : 45.30 (-5.66%)
KRYS : 58.44 (-2.36%)
INVO : 4.26 (-2.29%)
FOUR : 89.19 (-1.10%)
Krystal Biotech Appoints Andy Orth as Chief Commercial Officer

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, announced today the appointment of Andy Orth as Chief Commercial Officer. Mr. Orth has more than...

KRYS : 58.44 (-2.36%)
Krystal Biotech Announces Virtual Presentation of Data from its Vector-Encoded-Antibody Platform at ASGCT

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that it will present preclinical data from its vector-encoded-antibody platform...

KRYS : 58.44 (-2.36%)
Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced modifications to the Statistical Analysis Plan (SAP) in the ongoing Phase 3 study...

KRYS : 58.44 (-2.36%)
Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced positive results of its IND-enabling good laboratory practice (GLP) toxicology...

KRYS : 58.44 (-2.36%)
Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial of B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa

Krystal Biotech Inc., ("Krystal") (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that enrollment is complete in the pivotal GEM-3 study of B-VEC for dystrophic...

KRYS : 58.44 (-2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

See More

Key Turning Points

3rd Resistance Point 63.38
2nd Resistance Point 62.20
1st Resistance Point 60.32
Last Price 58.44
1st Support Level 57.27
2nd Support Level 56.09
3rd Support Level 54.21

See More

52-Week High 87.29
Fibonacci 61.8% 68.99
Fibonacci 50% 63.34
Last Price 58.44
Fibonacci 38.2% 57.69
52-Week Low 39.39

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar